MS drug trial aims to help PAD patients walk farther
NCT ID NCT06319339
Summary
This early-stage study is testing if a single dose of an existing drug, diroximel fumarate (Vumerity), can help people with peripheral artery disease (PAD) walk better. Researchers believe the drug may reduce harmful stress in blood vessels, improving blood flow to the legs. About 20 participants will take either the drug or a placebo, and their walking capacity and blood vessel function will be measured before and after.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Nebraska - Omaha
RECRUITINGOmaha, Nebraska, 68182, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.